Relating to breast implants, the Food and Drug Administration, and public health.

Summary

Expresses the sense of the House of Representatives that the Food and Drug Administration should: (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 19 September 1996

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 19 September 1996

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 19 September 1996

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.